GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:STSEY) » Definitions » EV-to-FCF

Stratec SE (Stratec SE) EV-to-FCF

: 788.66 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Stratec SE's Enterprise Value is $1,709.8 Mil. Stratec SE's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $2.2 Mil. Therefore, Stratec SE's EV-to-FCF for today is 788.66.

The historical rank and industry rank for Stratec SE's EV-to-FCF or its related term are showing as below:

STSEY' s EV-to-FCF Range Over the Past 10 Years
Min: -338.07   Med: 31.65   Max: 692.18
Current: 290.47

During the past 13 years, the highest EV-to-FCF of Stratec SE was 692.18. The lowest was -338.07. And the median was 31.65.

STSEY's EV-to-FCF is ranked worse than
95.16% of 372 companies
in the Medical Devices & Instruments industry
Industry Median: 26.405 vs STSEY: 290.47

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-19), Stratec SE's stock price is $26.25. Stratec SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.232. Therefore, Stratec SE's PE Ratio for today is 113.15.


Stratec SE EV-to-FCF Historical Data

The historical data trend for Stratec SE's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -143.76 248.28 39.49 -120.06 330.26

Stratec SE Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -120.06 -155.20 -23.68 -23.37 330.26

Competitive Comparison

For the Medical Devices subindustry, Stratec SE's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE EV-to-FCF Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Stratec SE's EV-to-FCF falls into.



Stratec SE EV-to-FCF Calculation

Stratec SE's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1709.815/2.168
=788.66

Stratec SE's current Enterprise Value is $1,709.8 Mil.
Stratec SE's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stratec SE  (OTCPK:STSEY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Stratec SE's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=26.25/0.232
=113.15

Stratec SE's share price for today is $26.25.
Stratec SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.232.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Stratec SE EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Stratec SE's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (Stratec SE) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus